Specifically, CHD showed a significant correlation with decreased levels of T-cell surface glycoprotein CD5 (CD5) (Beta: −0.15, 95% CI: −0.29 to −0.01, P = .042). The gene discussed is CD5; the disease is coronary artery disorder.